Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

Glioma molecular diagnostics move toward cheaper liquid biopsy assays

A 2023 review examines liquid biopsy tools for glioma diagnosis, weighing NGS, ddPCR, and qPCR against cost and marker scarcity.

A review of glioma liquid biopsy methods outlines NGS, ddPCR, and qPCR options and the need for cheaper…

Divarasib outperformed rival KRAS G12C drugs in metastatic non-small cell lung cancer, extending life by nearly six months…

A preprint in breast cancer identifies 666 concordant upregulated genes across RNA-seq workflows, with subtype and survival signals…

GUARD-LGG predicted early radiotherapy response in lower-grade glioma across training, external, and prospective cohorts before treatment began.

European multicenter data map TP53 Y220C in NSCLC, showing rare prevalence, frequent driver-negative tumors, and a link with…

A Frontiers in Immunology review examines myokine-driven gut-muscle signaling in rectal cancer and how it may influence ICI-related…

A JNCI review outlines multi-omics precision medicine, showing how AI and foundation models can improve disease modeling, stratification,…

Cadonilimab with gemcitabine and cisplatin achieved a 55.7% response rate in unresectable or metastatic biliary tract cancer in…

Moderna and Merck are moving to file their personalized cancer vaccine with the FDA, with approval now expected…

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds